In our study, comparing MYADM with other known lung cancer biomarkers by bioinformatic methods, we found MYADM was associated with ICAM1 and RAC1, suggesting that MYADM may be a prognostic factor for NSCLC. This evidence concerns the gene RAC1 and lung cancer.